Holding(s) in Company

In brief · summary, not quotable

Aberdeen Group plc has notified Renalytix PLC of an acquisition of voting rights, crossing the 5% threshold on September 8, 2026. The group now effectively holds and has delegated voting rights to 9.848687% of Renalytix PLC shares, representing 59,469,395 voting rights, due to participation in the Issuer’s First Tranche Shares of its WRAP Retail Offer. This disclosure reflects holdings managed by discretionary investment management entities within multiple client portfolios.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your RENX notes

Issuer Details

ISIN

GB00BYWL4Y04

Issuer Name

RENALYTIX PLC

UK or Non-UK Issuer

UK

Reason for Notification

An acquisition or disposal of voting rights

Details of person subject to the notification obligation

Name

Aberdeen Group plc

City of registered office (if applicable)

Edinburgh

Country of registered office (if applicable)

United Kingdom

Details of the shareholder

City of registered office (if applicable)

Country of registered office (if applicable)

Date on which the threshold was crossed or reached

08-Sep-2026

Date on which Issuer notified

09-Sep-2026

Total positions of person(s) subject to the notification obligation

Resulting situation on the date on which threshold was crossed or reached	9.848687	0.000000	9.848687	59,469,395
Position of previous notification (if applicable)		Below 5%	Below 5%	Below 5%
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB00BYWL4Y04			59,469,395	9.848687
Sub Total 8.A			59,469,395	9.848687

Financial Instruments according to (DTR5.3.1R.(1) (a))

Sub Total 8.B1

Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Sub Total 8.B2

Information in relation to the person subject to the notification obligation

Aberdeen Group plc

			Aberdeen Group plc	abrdn Holdings Limited
Aberdeen Group plc	abrdn Inc.	9.848687	0.000000	9.848687

In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

If date does not apply, explain below

Additional Information

This disclosure also reflects the fact that the voting rights effectively held indirectly by the underlying intermediate holding company abrdn Holdings Limited (“aHL”) and held by the underlying investment management entity abrdn Inc. ("aI”) increased above the 5% notifiable threshold due to the participation in the Issuer’s First Tranche Shares of its WRAP Retail Offer on 8th September 2026. aHL now effectively holds and aI holds the delegated voting rights to 9.848687% of the shares in Renalytix PLC.